Xavier M Teitsma

516 total citations
16 papers, 181 citations indexed

About

Xavier M Teitsma is a scholar working on Rheumatology, Genetics and Hematology. According to data from OpenAlex, Xavier M Teitsma has authored 16 papers receiving a total of 181 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Rheumatology, 7 papers in Genetics and 3 papers in Hematology. Recurrent topics in Xavier M Teitsma's work include Rheumatoid Arthritis Research and Therapies (13 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Systemic Lupus Erythematosus Research (6 papers). Xavier M Teitsma is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (13 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Systemic Lupus Erythematosus Research (6 papers). Xavier M Teitsma collaborates with scholars based in Netherlands, Switzerland and Germany. Xavier M Teitsma's co-authors include J. W. J. Bijlsma, Johannes W. G. Jacobs, Floris P. J. G. Lafeber, Michelle E A Borm, Jacob M. van Laar, Attila Pethö‐Schramm, Paco M J Welsing, Amy C. Harms, Pascal H P de Jong and Thomas Hankemeier and has published in prestigious journals such as PLoS ONE, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Xavier M Teitsma

15 papers receiving 179 citations

Peers

Xavier M Teitsma
Marian H. van Beers-Tas Netherlands
А. С. Авдеева Russia
Takayoshi Fujibayashi Japan
Peigen He China
Élodie Constant France
Lin‐Pierre Zhao France
Rosa Serrano Spain
Е. В. Зонова Russia
Regina Cseuz United States
Ching-Tsai Lin Taiwan
Marian H. van Beers-Tas Netherlands
Xavier M Teitsma
Citations per year, relative to Xavier M Teitsma Xavier M Teitsma (= 1×) peers Marian H. van Beers-Tas

Countries citing papers authored by Xavier M Teitsma

Since Specialization
Citations

This map shows the geographic impact of Xavier M Teitsma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier M Teitsma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier M Teitsma more than expected).

Fields of papers citing papers by Xavier M Teitsma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier M Teitsma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier M Teitsma. The network helps show where Xavier M Teitsma may publish in the future.

Co-authorship network of co-authors of Xavier M Teitsma

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier M Teitsma. A scholar is included among the top collaborators of Xavier M Teitsma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier M Teitsma. Xavier M Teitsma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Betts, Keith A., Raluca Ionescu‐Ittu, Lesley M. Butler, et al.. (2021). Classification, Prediction, and Concordance of Cognitive and Functional Progression in Patients with Mild Cognitive Impairment in the United States: A Latent Class Analysis. Journal of Alzheimer s Disease. 82(4). 1667–1682. 6 indexed citations
3.
Jacobs, Johannes W. G., Maria J. H. de Hair, Paco M J Welsing, et al.. (2020). Effect on efficacy and safety trial outcomes of also enrolling patients on ongoing glucocorticoid therapy in rheumatoid arthritis clinical trials of tocilizumab or adalimumab or methotrexate monotherapy. Annals of the Rheumatic Diseases. 79(4). 460–463. 6 indexed citations
4.
Teitsma, Xavier M, Jenny Devenport, Johannes W. G. Jacobs, et al.. (2020). Comprehensive exploratory autoantibody profiling in patients with early rheumatoid arthritis treated with methotrexate or tocilizumab. PLoS ONE. 15(12). e0241189–e0241189. 3 indexed citations
5.
6.
Teitsma, Xavier M, Johannes W G Jacobs, Attila Pethö‐Schramm, et al.. (2019). Explorative analyses of protein biomarkers in patients with early rheumatoid arthritis achieving sustained drug-free remission after treatment with tocilizumab- or methotrexate-based strategies: from transcriptomics to proteomics.. PubMed. 36(6). 976–983. 5 indexed citations
7.
8.
Teitsma, Xavier M, Johannes W. G. Jacobs, Paco M J Welsing, et al.. (2018). Inadequate response to treat-to-target methotrexate therapy in patients with new-onset rheumatoid arthritis: development and validation of clinical predictors. Annals of the Rheumatic Diseases. 77(9). 1261–1267. 32 indexed citations
9.
Pethö‐Schramm, Attila, Michelle E A Borm, Xavier M Teitsma, et al.. (2018). FRI0026 U-act-early trial 3 years follow-up. the longer effectiveness of treat-to-target strategies in early ra with tocilizumab, methotrexate, or their combination. Annals of the Rheumatic Diseases. 77. 560–560. 2 indexed citations
10.
Safy, M., J. W. G. Jacobs, M Edwardes, et al.. (2018). SAT0169 No evidence that concomitant glucocorticoid therapy affects efficacy and safety of tocilizumab monotherapy in rheumatoid arthritis clinical trials. Annals of the Rheumatic Diseases. 77. 945–945. 6 indexed citations
11.
Teitsma, Xavier M, J. W. G. Jacobs, J. M. W. Hazes, et al.. (2018). FRI0040 Development and validation of clinical predictors for inadequate response to treat-to-target methotrexate therapy in newly diagnosed ra patients. Annals of the Rheumatic Diseases. 77. 567–567. 1 indexed citations
12.
Teitsma, Xavier M, J. W. G. Jacobs, Attila Pethö‐Schramm, et al.. (2018). SAT0046 Transcript-protein associations in early ra patients achieving sustained drug-free remission after treatment with tocilizumab. Annals of the Rheumatic Diseases. 77. 888–888. 1 indexed citations
13.
Teitsma, Xavier M, Johannes W. G. Jacobs, Paco M J Welsing, et al.. (2017). Patient-reported outcomes in newly diagnosed early rheumatoid arthritis patients treated to target with a tocilizumab- or methotrexate-based strategy. Lara D. Veeken. 56(12). 2179–2189. 6 indexed citations
14.
Teitsma, Xavier M, Johannes W. G. Jacobs, Michal Mokrý, et al.. (2017). Identification of differential co-expressed gene networks in early rheumatoid arthritis achieving sustained drug-free remission after treatment with a tocilizumab-based or methotrexate-based strategy. Arthritis Research & Therapy. 19(1). 170–170. 14 indexed citations
15.
Teitsma, Xavier M, Johannes W. G. Jacobs, Paco M J Welsing, et al.. (2017). Radiographic joint damage in early rheumatoid arthritis patients: comparing tocilizumab- and methotrexate-based treat-to-target strategies. Lara D. Veeken. 57(2). 309–317. 14 indexed citations
16.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marian H. van Beers-Tas Breakdown of academic impact, for papers by А. С. Авдеева Breakdown of academic impact, for papers by Takayoshi Fujibayashi Breakdown of academic impact, for papers by Peigen He Breakdown of academic impact, for papers by Élodie Constant Breakdown of academic impact, for papers by Lin‐Pierre Zhao Breakdown of academic impact, for papers by Rosa Serrano Breakdown of academic impact, for papers by Е. В. Зонова Breakdown of academic impact, for papers by Regina Cseuz Breakdown of academic impact, for papers by Ching-Tsai Lin
Rankless by CCL
2026